165 related articles for article (PubMed ID: 36182582)
1. Noninferiority Trial Design: Opportunities and Challenges.
Adidharma W; Nguyen SN; Waljee JF
J Hand Surg Am; 2022 Nov; 47(11):1101-1106. PubMed ID: 36182582
[TBL] [Abstract][Full Text] [Related]
2. Pros and Cons of Noninferiority Trials.
Ofori S; Tornberg SV; Kilpeläinen TP; Tikkinen KAO; Guyatt GH; Witte LPW
Eur Urol Focus; 2023 Sep; 9(5):711-714. PubMed ID: 37880063
[TBL] [Abstract][Full Text] [Related]
3. Defining the noninferiority margin and analysing noninferiority: An overview.
Althunian TA; de Boer A; Groenwold RHH; Klungel OH
Br J Clin Pharmacol; 2017 Aug; 83(8):1636-1642. PubMed ID: 28252213
[TBL] [Abstract][Full Text] [Related]
4. Rationale for and methods of superiority, noninferiority, or equivalence designs in orthopaedic, controlled trials.
Vavken P
Clin Orthop Relat Res; 2011 Sep; 469(9):2645-53. PubMed ID: 21246313
[TBL] [Abstract][Full Text] [Related]
5. Understanding the Merits and Drawbacks of Noninferiority Trials in Cardiovascular Medicine.
Kaul S
Can J Cardiol; 2021 Sep; 37(9):1378-1393. PubMed ID: 34118378
[TBL] [Abstract][Full Text] [Related]
6. Non-inferiority Trial Design in Drug Development: A Primer for Cardiovascular Healthcare Professionals.
Angeli F; Verdecchia P; Reboldi G
Am J Cardiovasc Drugs; 2020 Jun; 20(3):229-238. PubMed ID: 31650521
[TBL] [Abstract][Full Text] [Related]
7. Noninferiority Clinical Trials: The Good, the Bad, and the Ugly.
Lesaffre E
Semin Liver Dis; 2018 May; 38(2):97-102. PubMed ID: 29871016
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness clinical trials in psychiatry: superiority, noninferiority, and the role of active comparators.
Leon AC
J Clin Psychiatry; 2011 Oct; 72(10):1344-9. PubMed ID: 21367350
[TBL] [Abstract][Full Text] [Related]
9. Some issues for the evaluation of noninferiority trials.
Xie X; Wang M; Ng V; Sikich N
J Comp Eff Res; 2018 Sep; 7(9):835-843. PubMed ID: 30192159
[TBL] [Abstract][Full Text] [Related]
10. Issues in noninferiority trials: the evidence in community-acquired pneumonia.
Fleming TR; Powers JH
Clin Infect Dis; 2008 Dec; 47 Suppl 3(Suppl 3):S108-20. PubMed ID: 18986275
[TBL] [Abstract][Full Text] [Related]
11. Protocol adherence rates in superiority and noninferiority randomized clinical trials published in high impact medical journals.
Bamat NA; Ekhaguere OA; Zhang L; Flannery DD; Handley SC; Herrick HM; Ellenberg SS
Clin Trials; 2020 Oct; 17(5):552-559. PubMed ID: 32666826
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based medicine: the design and interpretation of noninferiority clinical trials in veterinary medicine.
Freise KJ; Lin TL; Fan TM; Recta V; Clark TP
J Vet Intern Med; 2013; 27(6):1305-17. PubMed ID: 24128266
[TBL] [Abstract][Full Text] [Related]
13. Noninferiority Trials to Evaluate Drug Effects in Rheumatoid Arthritis.
Rothwell R; Nikolov NP; Maynard JW; Levin G
Arthritis Rheumatol; 2020 Aug; 72(8):1258-1265. PubMed ID: 32182406
[TBL] [Abstract][Full Text] [Related]
14. Evaluating equivalence and noninferiority trials.
Dasgupta A; Lawson KA; Wilson JP
Am J Health Syst Pharm; 2010 Aug; 67(16):1337-43. PubMed ID: 20689122
[TBL] [Abstract][Full Text] [Related]
15. Noninferiority Randomized Controlled Trials.
Kim KS; Chan AW; Belley-Côté EP; Drucker AM
J Invest Dermatol; 2022 Jul; 142(7):1773-1777. PubMed ID: 35715156
[TBL] [Abstract][Full Text] [Related]
16. Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.
Aberegg SK; Hersh AM; Samore MH
J Gen Intern Med; 2018 Jan; 33(1):88-96. PubMed ID: 28875400
[TBL] [Abstract][Full Text] [Related]
17. The Need for Combined Assessment of Multiple Outcomes in Noninferiority Trials in Oncology.
Jatoi I; Gail MH
JAMA Oncol; 2020 Mar; 6(3):420-424. PubMed ID: 31830235
[TBL] [Abstract][Full Text] [Related]
18. Most noninferiority trials were not designed to preserve active comparator treatment effects.
Tsui M; Rehal S; Jairath V; Kahan BC
J Clin Epidemiol; 2019 Jun; 110():82-89. PubMed ID: 30858020
[TBL] [Abstract][Full Text] [Related]
19. Interpreting the results of noninferiority trials-a review.
Cuzick J; Sasieni P
Br J Cancer; 2022 Nov; 127(10):1755-1759. PubMed ID: 36104512
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of noninferiority and equivalence trials: ignoring trial design leads to differing and possibly misleading conclusions.
Acuna SA; Dossa F; Baxter N
J Clin Epidemiol; 2020 Nov; 127():134-141. PubMed ID: 32540386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
